SLC5A4P1

Across TCGA pan-cancer cohorts, SLC5A4P1 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated SLC5A4P1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SLC5A4P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC5A4P1 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

ACC, GBM, and SKCM are the cancer types where SLC5A4P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.068	0.667	.005	36	view →
GBM	OS	Tertile	All	0.148	0.421	.004	18	view →
SKCM	DFS	Tertile	All	0.415	0.734	.003	18	view →
BLCA	OS	Tertile	III,IV	1.000	0.244	.033	15	view →
KIRC	DFS	Tertile	IV	0.210	0.539	.011	12	view →
THCA	DFS	Tertile	All	0.699	0.910	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

SLC5A4P1–ACC (DFS)

Open the ACC breakdown →